Loading...

MiMedx Group, Inc.

MDXG•NASDAQ
Healthcare
Biotechnology
$3.42
$-0.01(-0.29%)
U.S. Market opens in 59h 46m

MiMedx Group, Inc. (MDXG) Stock Overview

Explore MiMedx Group, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap507.4M
P/E Ratio10.42
EPS (TTM)$0.32
ROE0.21%
Fundamental Analysis

AI Price Forecasts

1 Month$3.63
3 Months$0.25
1 Year Target$5.71

MDXG Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of MiMedx Group, Inc. (MDXG) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 22.48, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $5.71.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 10.42 and a market capitalization of 507.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.44%
5-Day Change
-15.47%
1-Month Change
-21.67%
3-Month Change
-36.99%
6-Month Change
-48.95%
Year-to-Date (YTD) Change
-49.56%
1-Year Change
-48.88%
3-Year Change
0.74%
5-Year Change
-69.89%
All-Time (Max) Change
-26.40%

Contact Information

https://www.mimedx.com
770 651 9100
1775 West Oak Commons Court, NE, Marietta, GA, 30062

Company Facts

837 Employees
IPO DateFeb 12, 2008
CountryUS
Actively Trading

Frequently Asked Questions